Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PASG

Passage BIO, Inc.

CIK 0001787297 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$4.71
↓ 0.11 (-2.28%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$15.46M
P/E Ratio
-0.29
EPS
-14.35
Dividend Yield
Not covered
52W Position
22%
Beta
3.03

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.32
P/S
Not covered
EV/Revenue
Not covered
ROE
-320.6%
Valuation data covers 8,499/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 22%
$0.35$20.00

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$45.52M
Total Assets
$62.28M
Free Cash Flow
–

Recent news